Literature DB >> 9689077

Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.

D Panda1, K DeLuca, D Williams, M A Jordan, L Wilson.   

Abstract

Cryptophycin-52 (LY355703) is a new synthetic member of the cryptophycin family of antimitotic antitumor agents that is currently undergoing clinical evaluation. At high concentrations (>/=10 times the IC50), cryptophycin-52 blocked HeLa cell proliferation at mitosis by depolymerizing spindle microtubules and disrupting chromosome organization. However, low concentrations of cryptophycin-52 inhibited cell proliferation at mitosis (IC50 = 11 pM) without significantly altering spindle microtubule mass or organization. Cryptophycin-52 appears to be the most potent suppressor of microtubule dynamics found thus far. It suppressed the dynamic instability behavior of individual microtubules in vitro (IC50 = 20 nM), reducing the rate and extent of shortening and growing without significantly reducing polymer mass or mean microtubule length. Using [3H]cryptophycin-52, we found that the compound bound to microtubule ends in vitro with high affinity (Kd, 47 nM, maximum of approximately 19.5 cryptophycin-52 molecules per microtubule). By analyzing the effects of cryptophycin-52 on dynamics in relation to its binding to microtubules, we determined that approximately 5-6 molecules of cryptophycin-52 bound to a microtubule were sufficient to decrease dynamicity by 50%. Cryptophycin-52 became concentrated in cells 730-fold, and the resulting intracellular cryptophycin-52 concentration was similar to that required to stabilize microtubule dynamics in vitro. The data suggest that cryptophycin-52 potently perturbs kinetic events at microtubule ends that are required for microtubule function during mitosis and that it acts by forming a reversible cryptophycin-52-tubulin stabilizing cap at microtubule ends.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689077      PMCID: PMC21335          DOI: 10.1073/pnas.95.16.9313

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends.

Authors:  D Panda; M A Jordan; K C Chu; L Wilson
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

Review 2.  Microtubule dynamics: taking aim at a moving target.

Authors:  L Wilson; M A Jordan
Journal:  Chem Biol       Date:  1995-09

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Microtubule treadmilling in vivo.

Authors:  V I Rodionov; G G Borisy
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

5.  Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.

Authors:  C D Smith; X Zhang
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 6.  Microtubule treadmills--possible molecular machinery.

Authors:  R L Margolis; L Wilson
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

7.  Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action.

Authors:  D Panda; H P Miller; K Islam; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

8.  Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.

Authors:  D Panda; R H Himes; R E Moore; L Wilson; M A Jordan
Journal:  Biochemistry       Date:  1997-10-21       Impact factor: 3.162

9.  Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.

Authors:  R Bai; R E Schwartz; J A Kepler; G R Pettit; E Hamel
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

10.  Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules.

Authors:  L D Belmont; T J Mitchison
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

View more
  10 in total

Review 1.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 2.  New insights into mechanisms of resistance to microtubule inhibitors.

Authors:  Anutosh Ganguly; Fernando Cabral
Journal:  Biochim Biophys Acta       Date:  2011-06-29

3.  Taxol suppresses dynamics of individual microtubules in living human tumor cells.

Authors:  A M Yvon; P Wadsworth; M A Jordan
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

Review 4.  Drugs that target dynamic microtubules: a new molecular perspective.

Authors:  Richard A Stanton; Kim M Gernert; James H Nettles; Ritu Aneja
Journal:  Med Res Rev       Date:  2011-03-04       Impact factor: 12.944

Review 5.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

6.  Discovery of rare and highly toxic microcystins from lichen-associated cyanobacterium Nostoc sp. strain IO-102-I.

Authors:  Ilona Oksanen; Jouni Jokela; David P Fewer; Matti Wahlsten; Jouko Rikkinen; Kaarina Sivonen
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

7.  Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site.

Authors:  Jubina B Venghateri; Tilak Kumar Gupta; Paul J Verma; Ambarish Kunwar; Dulal Panda
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 8.  Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology.

Authors:  Noora Barzkar; Saeid Tamadoni Jahromi; Hadi Bolooki Poorsaheli; Fabio Vianello
Journal:  Mar Drugs       Date:  2019-08-08       Impact factor: 5.118

9.  An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.

Authors:  Ankit Rai; Avadhesha Surolia; Dulal Panda
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

10.  Fam70A binds Wnt5a to regulate meiosis and quality of mouse oocytes.

Authors:  Na-Na Zhang; Teng Zhang; Wen-Yi Gao; Xin Wang; Zi-Bin Wang; Jin-Yang Cai; Yang Ma; Cong-Rong Li; Xi-Chen Chen; Wen-Tao Zeng; Fan Hu; Jian-Min Li; Zhi-Xia Yang; Chun-Xiang Zhou; Dong Zhang
Journal:  Cell Prolif       Date:  2020-05-11       Impact factor: 6.831

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.